Understanding The Potential Drug Targets of CALML4 (G91860)

Target Name: CALML4

NCBI ID: G91860

CALML4

Understanding The Potential Drug Targets of CALML4

CALML4 (CALM-like molecule 4) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the Calbindin family of proteins, which are known for their ability to interact with and modulate the activity of other proteins. One of the unique features of CALML4 is its ability to interact with the protein known as p16INK4a, which is a key regulator of cell growth and survival.

Recent studies have suggested that CALML4 may have a variety of potential functions, including the regulation of cell growth, the development of cancer, and the regulation of inflammation. In addition, it has been shown to play a role in the development of certain diseases, such as ALZHEIMER'S DISEASE and Parkinson's DISEASE.

One of the main reasons for the interest in CALML4 is its potential as a drug target. By interacting with the protein known as p16INK4a, it is possible to modulate the activity of this protein and potentially inhibit its functions. This could lead to a variety of potential therapeutic benefits, including the treatment of certain diseases.

One of the key challenges in studying the potential drug targets of CALML4 is its expression in different tissues and the difficulty in accessing it in these tissues. Despite this, researchers have been able to study its function in a variety of experimental contexts. For example, studies have shown that CALML4 is involved in the regulation of cell growth and that it interacts with the protein known as p16INK4a. These findings suggest that CALML4 may be a potential drug target for the treatment of certain diseases.

In addition to its potential as a drug target, CALML4 is also of interest as a biomarker. Its expression has been shown to be associated with the development of certain diseases, such as ALZHEIMER'S DISEASE and Parkinson's DISEASE. This suggests that its levels may be a useful indicator of the risk of these diseases and could potentially be used as a biomarker for these conditions.

Overall, the study of CALML4 is an exciting area of research with potential for the treatment of a variety of diseases. While further studies are needed to fully understand its functions and potential as a drug target and biomarker, the study of CALML4 is a promising example of the potential of protein studies to advance our understanding of disease and to develop new treatments.

Protein Name: Calmodulin Like 4

The "CALML4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CALML4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets